Q3 2022 Holdings
Filed 2022-11-14 | 73 holdings | $324.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $11 | 66,666 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $45 | 266,666 | 0.0% |
| Bellicum Pharmaceuticals Inc(BLCMEUR) | COM NEW | 079481404 | $68 | 56,950 | 0.0% |
| Codiak Biosciences Inc(32W) | COM | 192010106 | $382 | 488,157 | 0.0% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $619 | 209,227 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $1.1K | 2,913,091 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $1.9K | 2,250,000 | 0.0% |
| Omega Alpha Spac | CL A | G6749V107 | $2.0K | 200,000 | 0.0% |
| Gemini Therapeutics Inc | COM | 36870G105 | $2.1K | 1,300,000 | 0.0% |
| Alaunos Therapeutics Inc | COM | 98973P101 | $2.6K | 1,500,000 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $3.4K | 1,054,000 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $3.5K | 2,202,333 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $3.8K | 2,134,598 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $4.0K | 400,000 | 0.0% |
| Panacea Acquisition Corp II | CL A SHS | G6882C106 | $4.9K | 500,000 | 0.0% |
| Eqrx Inc | COM | 26886C107 | $5.0K | 1,000,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $5.0K | 500,000 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $5.0K | 1,251,137 | 0.0% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $5.2K | 892,057 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $5.3K | 686,347 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $5.4K | 3,284,072 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $5.7K | 1,175,000 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $6.4K | 698,861 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $6.5K | 500,000 | 0.0% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $6.7K | 459,836 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $7.8K | 350,000 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $8.1K | 1,400,000 | 0.0% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $10.8K | 570,417 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $16.0K | 1,224,892 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $18.1K | 275,000 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $18.2K | 300,000 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $18.2K | 1,522,559 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $18.3K | 1,121,327 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $18.5K | 1,935,133 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $19.3K | 2,500,000 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $19.6K | 1,250,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $21.7K | 600,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $22.1K | 200,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $23.4K | 1,466,051 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $23.5K | 1,210,192 | 0.0% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $23.8K | 1,189,943 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $24.3K | 2,325,000 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $24.9K | 6,871,642 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $28.3K | 831,495 | 0.0% |
| Veru Inc(VERUEUR) | COM | 92536C103 | $28.8K | 2,500,000 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $29.7K | 850,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $31.1K | 1,239,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $32.9K | 2,202,812 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $33.2K | 1,300,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $33.8K | 3,200,000 | 0.0% |